跳轉至內容
Merck
  • Differential effects of topical corticosteroid and calcineurin inhibitor on the epidermal tight junction.

Differential effects of topical corticosteroid and calcineurin inhibitor on the epidermal tight junction.

Experimental dermatology (2012-11-24)
Sang E Lee, Yuri Choi, Song-Ee Kim, Eun B Noh, Soo-Chan Kim
摘要

Tight junction (TJ) is one of the functional barriers present in the skin. Although topical corticosteroids and calcineurin inhibitors are used widely for atopic dermatitis, the effect of these agents on TJs has not been reported. We investigated the structural changes of TJs in mice skin after application of 0.05% clobetasol propionate or 0.1% tacrolimus ointment for 10 days. Clobetasol caused epidermal thinning and decreased collagen density. Basal transepidermal water loss was significantly increased in clobetasol-treated versus vehicle- or tacrolimus-treated skin. Confocal immunofluorescence showed that clobetasol altered the structure of claudin-1,-4 and occludin. Tacrolimus also caused morphological alteration of occludin. Western blot and real-time PCR revealed that clobetasol significantly decreased claudin-1,-4 and occludin, whereas tacrolimus did not significantly affect claudin-1 and -4 but downregulated occludin to a lesser extent compared to clobetasol. In conclusion, we suggest that downregulation of TJ proteins expression is another pathomechanism of corticosteroid-induced permeability barrier disruption.

材料
產品編號
品牌
產品描述

Supelco
丙酸氯倍他索, analytical standard
暫時無法取得訂價和供貨情況
丙酸氯倍他索, European Pharmacopoeia (EP) Reference Standard
暫時無法取得訂價和供貨情況